T. Rowe Price Associates
SVRA icon

T. Rowe Price Associates’s Savara SVRA Stock Holding History

T. Rowe Price Associates’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$775K Buy
125,676
+24,204
+24% +$130K ﹤0.01% 2434
2026
Q1 		$555K Buy
101,472
+31,936
+46% +$178K ﹤0.01% 2402
2025
Q4 		$420K Buy
69,536
+2,116
+3% +$10.4K ﹤0.01% 2474
2025
Q3 		$241K Buy
67,420
+11,753
+21% +$34.8K ﹤0.01% 2712
2025
Q2 		$127K Buy
55,667
+3,545
+7% +$9.64K ﹤0.01% 2845
2025
Q1 		$145K Buy
52,122
+8,454
+19% +$23.3K ﹤0.01% 2741
2024
Q4 		$135K Buy
43,668
+5,236
+14% +$18.3K ﹤0.01% 2791
2024
Q3 		$163K Buy
38,432
+7,448
+24% +$32.9K ﹤0.01% 2716
2024
Q2 		$125K Sell
30,984
-2,708
-8% -$12K ﹤0.01% 2713
2024
Q1 		$168K Buy
33,692
+4,625
+16% +$22.3K ﹤0.01% 2671
2023
Q4 		$137K Buy
29,067
+1,747
+6% +$6.7K ﹤0.01% 2654
2023
Q3 		$104K Sell
27,320
-8,239
-23% -$29.4K ﹤0.01% 2661
2023
Q2 		$114K Buy
35,559
+6,599
+23% +$15.5K ﹤0.01% 2672
2023
Q1 		$57K Hold
28,960
– – ﹤0.01% 2773
2022
Q4 		$45K Hold
28,960
– – ﹤0.01% 2826
2022
Q3 		$45K Buy
28,960
+6,200
+27% +$9.98K ﹤0.01% 2853
2022
Q2 		$35K Buy
22,760
+900
+4% +$1.18K ﹤0.01% 2897
2022
Q1 		$29K Buy
21,860
+4,600
+27% +$5.54K ﹤0.01% 2952
2021
Q4 		$21K Hold
17,260
– – ﹤0.01% 2958
2021
Q3 		$24K Hold
17,260
– – ﹤0.01% 2932
2021
Q2 		$29K Sell
17,260
-1,743
-9% -$3.13K ﹤0.01% 2909
2021
Q1 		$40K Buy
19,003
+7,200
+61% +$12.3K ﹤0.01% 2833
2020
Q4 		$14K Buy
+11,803
New +$14.2K ﹤0.01% 2661

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

T. Rowe Price Associates's SVRA Position: Q2 2026 in Review

T. Rowe Price Associates increased its Savara (SVRA) stake by 24% in Q2 2026, buying an estimated $130K and bringing the position to 125,676 shares worth $775K. The position accounts for ﹤0.01% of the portfolio, ranked #2434.

T. Rowe Price Associates first reported a position in SVRA in Q4 2020 and has held it in 23 quarters since. 181 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • T. Rowe Price Associates held 125,676 shares of Savara worth $775K as of Q2 2026.
  • T. Rowe Price Associates bought 24,204 Savara shares in Q2 2026, an estimated $130K.
  • Savara made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2434 holding.
  • T. Rowe Price Associates first reported a position in Savara in Q4 2020 and has held it in 23 quarters since.
  • 181 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.